Skip to main content

Advertisement

Log in

High seroprevalence of human herpesvirus type 8 in patients with hepatocellular carcinoma

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Cirrhosis patients have immunologic insufficiency and a high seroprevalence of human herpesvirus type 8 (HHV-8). Nearly all hepatocellular carcinoma (HCC) patients are cirrhotic and have immunoabnormalities. This study aimed to assess the HHV-8 seroprevalence and hemograms in HCC patients. Blood samples from 95 HCC patients, 95 age-, sex-, and Child–Pugh class-matched cirrhotics, and 95 age- and sex-matched healthy controls were analyzed for anti-HHV-8 antibodies, HHV-8 DNA, and lymphocyte, monocyte, and platelet counts. HCC patients had lower lymphocyte and platelet counts and a higher monocyte count than the healthy controls (each p < 0.0001). HCC patients, and particularly those with a severe Child–Pugh class, had higher platelet counts than the corresponding cirrhosis patients (p = 0.003 and 0.002, respectively). HHV-8 seropositivity and antibody titers in HCC patients were comparable with values in cirrhosis patients and were much higher than in controls (both p < 0.0001). HCC patients, but not cirrhosis patients, had a higher prevalence of high anti-HHV-8 antibody titers (≥1:160) than healthy controls (p = 0.003). HCC patients with lymphopenia or thrombocytopenia had lower HHV-8 seropositivity than those without lymphopenia and thrombocytopenia (p = 0.04 and 0.01, respectively). One each of HCC and cirrhosis patients were positive for HHV-8 DNA. HCC patients seemed to suffer from less severe or shorter duration of portal hypertension compared with Child–Pugh class-matched cirrhosis patients. HCC patients had a high HHV-8 seroprevalence, which seemed to be inversely associated with lymphopenia and thrombocytopenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Boshoff C, Weiss R (2002) AIDS-related malignancies. Nat Rev Cancer 2:373–382

    Article  CAS  PubMed  Google Scholar 

  2. Su CC, Li CF, Liao YL, Lin CN, Lu JJ (2005) Immunohistochemical and molecular assessment of human herpesvirus type 8 in gastrointestinal tumours. J Clin Pathol 58:856–859

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Al-Khader AA, Shaheen FA (2004) Posttransplant complications encountered in renal transplantation in the Middle East. Transplant Proc 36:180–183

    Article  CAS  PubMed  Google Scholar 

  4. Rady PL, Hodak E, Yen A, Memar O, Trattner A, Feinmesser M, David M, Hudnall SD, Tyring SK (1998) Detection of human herpesvirus-8 DNA in Kaposi’s sarcomas from iatrogenically immunosuppressed patients. J Am Acad Dermatol 38:429–437

    Article  CAS  PubMed  Google Scholar 

  5. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J (1984) Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4:53–58

    Article  CAS  PubMed  Google Scholar 

  6. Lombardo L, Capaldi A, Poccardi G, Vineis P (1995) Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis. Int J Clin Lab Res 25:153–156

    Article  CAS  PubMed  Google Scholar 

  7. Fiuza C, Salcedo M, Clemente G, Tellado JM (2000) In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 182:526–533

    Article  CAS  PubMed  Google Scholar 

  8. Chou AL, Huang WW, Tsao SM, Li CT, Su CC (2008) Human herpesvirus type 8 in patients with cirrhosis: correlation with sex, alcoholism, hepatitis B virus, disease severity, and thrombocytopenia. Am J Clin Pathol 130:231–237

    Article  PubMed  Google Scholar 

  9. Chou AL, Huang WW, Lin MN, Su CC (2010) Human herpesvirus type 8 in patients with cirrhosis independent of thrombocytopenia. J Clin Pathol 63:254–258

    Article  CAS  PubMed  Google Scholar 

  10. Monto A, Wright TL (2001) The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 28:441–449

    Article  CAS  PubMed  Google Scholar 

  11. Wands JR (2004) Prevention of hepatocellular carcinoma. N Engl J Med 351:1567–1570

    Article  CAS  PubMed  Google Scholar 

  12. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649

    Article  CAS  PubMed  Google Scholar 

  13. Ninomiya T, Akbar SM, Masumoto T, Horiike N, Onji M (1999) Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol 31:323–331

    Article  CAS  PubMed  Google Scholar 

  14. Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132:2328–2339

    Article  PubMed  Google Scholar 

  15. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J; EASL Panel of Experts on HCC (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430

    Article  CAS  PubMed  Google Scholar 

  16. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M; American Joint Committee on Cancer (AJCC) (2002) AJCC cancer staging manual, 6th edn. Springer-Verlag, New York

    Book  Google Scholar 

  17. O’Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R (1980) Malnutrition and immuno-incompetencein patients with liver disease. Lancet 2:615–617

  18. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386–2393

    Article  CAS  PubMed  Google Scholar 

  19. Su CC, Tsai JP, Lin MN, Hsieh TC, Tseng RC, Chu TY (2013) High seroprevalence of human herpesvirus type 8 in patients with end-stage renal disease in Taiwan. J Clin Virol 58:89–93

    Article  CAS  PubMed  Google Scholar 

  20. Leevy CB, Elbeshbeshy HA (2005) Immunology of alcoholic liver disease. Clin Liver Dis 9:55–66

    Article  PubMed  Google Scholar 

  21. Carr BI, Guerra V, De Giorgio M, Fagiuoli S, Pancoska P (2012) Small hepatocellular carcinomas and thrombocytopenia. Oncology 83:331–338

    Article  CAS  PubMed  Google Scholar 

  22. Cao M, Cabrera R, Xu Y, Firpi R, Zhu H, Liu C, Nelson DR (2007) Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells. Lab Invest 87:582–590

    CAS  PubMed  Google Scholar 

  23. Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG (2007) HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol 46:719–726

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Sitia G, Aiolfi R, Di Lucia P, Mainetti M, Fiocchi A, Mingozzi F, Esposito A, Ruggeri ZM, Chisari FV, Iannacone M, Guidotti LG (2012) Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci U S A 109:E2165–E2172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K (2010) Development of monocytes, macrophages, and dendritic cells. Science 327:656–661

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Bonacini M, Govindarajan S, Kohla M, Lai MM, Lindsay KL (2007) Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers. Minerva Gastroenterol Dietol 53:1–7

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants DTCRD95(2)-04 and DTCRD97-04from the Buddhist Dalin Tzu Chi Hospital, Chiayi, Taiwan.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to C.-C. Su or T.-Y. Chu.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 32 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Su, CC., Tseng, KC., Lin, MN. et al. High seroprevalence of human herpesvirus type 8 in patients with hepatocellular carcinoma. Eur J Clin Microbiol Infect Dis 34, 55–62 (2015). https://doi.org/10.1007/s10096-014-2206-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2206-8

Keywords

Navigation